10 Cash-Rich Undervalued Stocks To Invest In

3. MetLife, Inc. (NYSE:MET)

P/E Ratio as of March 3: 14.51

TTM Operating Cash Flow as of December 31, 2024: $14,598,000,000

Number of Hedge Fund Holders: 54

MetLife, Inc. (NYSE:MET) is a New York-based global financial services company specializing in insurance, annuities, employee benefits, and asset management. MetLife is the first insurer to add mental health support to its New Hampshire Paid Family Medical Leave (PFML) program, offering TELUS Health’s Cognitive Behavioral Therapy to help employees with anxiety, depression, and more. It ranks 3rd on our list of the best cash rich stocks to buy.

The company reported a net income of $4.2 billion in 2024, a significant increase from $1.4 billion in 2023, with earnings per share rising 228% to $5.94. The return on equity stood at 16.9%, and MetLife, Inc. (NYSE:MET) maintained $5.1 billion in cash and liquid assets as of December 31, 2024, exceeding its target buffer of $3 billion to $4 billion. The company also increased its free cash flow commitment to $25 billion over five years, up from $20 billion. On January 7, 2025, MetLife, Inc. (NYSE:MET) declared a quarterly dividend of $0.545 per share, payable on March 11 to shareholders on record as of February 4.

According to Insider Monkey’s fourth quarter database, 54 hedge funds held stakes in MetLife, Inc. (NYSE:MET), up from 37 funds in the prior quarter. Pzena Investment Management was the biggest stakeholder of the company, with 8.80 million shares worth $720.8 million.